Oncotarget

Pathology

Publish papers on Pathology in the journal with IF 6.63

Under the leadership of Michael Lisanti, the former Editor-in-Chief of the American Journal of Pathology (AJP) and its corresponding Editorial Board, we have launched the Pathology section in Oncotarget

Oncotarget (founded in May 2010) has received an impact factor 6.63 two years in a row.

The popularity and success of rapidly growing Oncotarget prompted us to launch new sections on specific disciplines, including Pathology.

There are several advantages of the Pathology Section of Oncotarget compared with other Pathology journals

  1. Higher impact factor
  2. Ultra-rapid publication  
  3. You may submit a paper rejected by other leading journals with reviews and rebuttal. The decision can be made within 1-6 days.

Accepted papers can appear online and in PubMed/Medline in 2-5 days after acceptance.

Submission is centralized via Oncotarget submission system. Please choose Pathology section.

Instructions to authors are common for all sections of Oncotarget. The paper will be published in Oncotarget and labeled as Section on Pathology. Submit your paper now.

Editor-in-Chief

Senior Associate Editors

Associate Editors



Copyright @ 2016 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC